Clinical Trial Update: The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial investigates using a combination of teriparatide (Forteo) and denosumab for osteoporosis; the current status is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Forteo (teriparatide)
• Prolia (denosumab)

Snippet

Sponsor: Health Research, Inc. | Conditions: Osteoporosis | Phase 4 | Status: UNKNOWN